<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:atom="http://www.w3.org/2005/Atom"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:media="http://search.yahoo.com/mrss/">
<channel>
    
        <item>
            <title>Pfizer seeks emergency use of Covid-19 vaccine - The Daily Guardian</title>
            <link>https://latest.thedailyguardian.com/medically-speaking/pfizer-seeks-emergency-use-of-covid-19-vaccine/</link>
            <guid>https://latest.thedailyguardian.com/medically-speaking/pfizer-seeks-emergency-use-of-covid-19-vaccine/</guid>
            <pubDate>November 21, 2020, 8:43 am</pubDate>
            <description><![CDATA[Pfizer has announced that its vaccine is 95% effective on the basis of its Phase-3 trials. On Friday, Pfizer said that it is asking US regulators to allow the emergency use of its Covid-19 vaccine. The company announced that they will submit a request to the US Food and Drug Administration (FDA) for Emergency Use [&hellip;]
]]></description>
            <content:encoded><![CDATA[
<p>Pfizer has announced that its vaccine is 95% effective on the basis of its Phase-3 trials. On Friday, Pfizer said that it is asking US regulators to allow the emergency use of its Covid-19 vaccine.</p>



<p>The company announced that they will submit a request to the US Food and Drug Administration (FDA) for Emergency Use Authorisation, which will potentially enable the use of the vaccine in high-risk populations in the US by mid to end of December 2020.</p>



<p>“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of Covid-19 globally. Filing in the US represents a critical milestone in our journey to deliver a Covid-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr Albert Borla, Pfizer CEO and chairman.</p>
]]></content:encoded>
            <media:content url="https://latest.thedailyguardian.com/wp-content/uploads/2020/11/Pfizer.jpg" type="image/jpeg" width="1200" height="675"/>
            <dc:creator>Shalini Bhardwaj</dc:creator>
            <category></category>
        </item>
</channel>
</rss>